1. Kuhn J, Klein PM, Danaf N Al, Nordin JZ, Reinhard S, Loy DM, Hoehn M, Andaloussi S El, Lamb DC, Wagner E, Aoki Y, Lehto T, Laechelt U.: Supramolecular Assembly of Aminoethylene-Lipopeptide PMO Conjugates into RNA Splice-Switching Nanomicelles. Advanced Functional Materials. 2019
2. Sato M, Shiba N, Miyazaki D, Shiba Y, Echigoya Y, Yokota T, Takizawa H, Aoki Y, Takeda S, Nakamura A.: Amelioration of intracellular Ca2+ regulation by exon-45 skipping in Duchenne muscular dystrophy-induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun. 26;520(1):179-185, Nov, 2019
3. Echigoya Y, Lim KRQ, Melo D, Bao B, Trieu N, Mizobe Y, Maruyama R, Mamchaoui K, Tanihata J, Aoki Y, Takeda S, Mouly V, Duddy W, Yokota T.: Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene. Mol Ther. 6;27(11):2005-2017, 2019
4. Tsoumpra MK, Sawatsubashi S, Imamura M, Fukumoto S, Takeda S, Matsumoto T, Aoki Y.: Dystrobrevin alpha gene is a direct target of the vitamin D receptor in muscle. J Mol Endocrinol. 64(3):195-208, Apr, 2020
5. Tsoumpra MK, Fukumoto S, Matsumoto T, Takeda S, Wood MJA, Aoki Y.: Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases. EBioMedicine. 45:630-645, Jul, 2019
6. Motohashi N, Shimizu-Motohashi Y, Roberts TC, Aoki Y.: Potential Therapies Using Myogenic Stem Cells Combined with Bio-Engineering Approaches for Treatment of Muscular Dystrophies. Cells. 11;8(9), Sep, 2019
7. Nordin JZ, Aoki Y.: Autoimmune response and its long-term consequences after exon-skipping therapy in a Duchenne muscular dystrophy mouse model. J Pathol. 249(3):271-273, Nov, 2019
8. Sato M, Takizawa H, Nakamura A, Turner BJ, Shabanpoor F, Aoki Y.: Application of Urine-Derived Stem Cells to Cellular Modeling in Neuromuscular and Neurodegenerative Diseases. Front Mol Neurosci. 5;12:297, Dec, 2019
9. 青木吉嗣,武田伸一: アンチセンス・モルフォリノ核酸医薬の特徴と研究動向,「PHARM TECH JAPAN」連載, 「核酸医薬品の創出に向けた産官学の取り組み」第4回, 2019
10. 橋本泰昌, 武田伸一, 青木吉嗣: アンチセンス医薬開発の最前線, (2)神経・筋疾患に対するアンチセンス医薬品, 医薬品医療機器レギュラトリーサイエンス財団, 50巻, 2019年3月号, 142-149, 2019.